Literature DB >> 8910390

Molecular and pharmacological characterization of native cortical gamma-aminobutyric acidA receptors containing both alpha1 and alpha3 subunits.

F Araujo1, S Tan, D Ruano, H Schoemaker, J Benavides, J Vitorica.   

Abstract

We have investigated the existence, molecular composition, and benzodiazepine binding properties of native cortical alpha1-alpha3 gamma-aminobutyric acidA (GABAA) receptors using subunit-specific antibodies. The co-existence of alpha1 and alpha3 subunits in native GABAA receptors was demonstrated by immunoblot analysis of the anti-alpha1- or anti-alpha3-immunopurified receptors and by immunoprecipitation experiments of the [3H]zolpidem binding activity. Furthermore, immunodepletion experiments indicated that the alpha1-alpha3 GABAA receptors represented 54.7 +/- 5.0 and 23.6 +/- 3.3% of the alpha3 and alpha1 populations, respectively. Therefore, alpha1 and alpha3 subunits are associated in the same native GABAA receptor complex, but, on the other hand, these alpha1-alpha3 GABAA receptors from the cortex constitute a large proportion of the total alpha3 population and a relatively minor component of the alpha1 population. The pharmacological analysis of the alpha1- or alpha3-immunopurified receptors demonstrated the presence of two different benzodiazepine binding sites in each receptor population with high (type I binding sites) and low (type II binding sites) affinities for zolpidem and Cl 218,872. These results indicate the existence of native GABAA receptors possessing both alpha1 and alpha3 subunits, with alpha1 and alpha3 subunits expressing their characteristic benzodiazepine pharmacology. The molecular characterization of the anti-alpha1-anti-alpha3 double-immunopurified receptors demonstrated the presence of stoichiometric amounts of alpha1 and alpha3 subunits, associated with beta2/3, and gamma2 subunits. The pharmacological analysis of alpha1-alpha3 GABAA receptors demonstrated that, despite the fact that each alpha subunit retained its benzodiazepine binding properties, the relative proportion between type I and II binding sites or between 51- and 59-61-kDa [3H]Ro15-4513-photolabeled peptides was 70:30. Therefore, the alpha1 subunit is pharmacologically predominant over the alpha3 subunit. These results indicate the existence of active and nonactive alpha subunits in the native alpha1-alpha3 GABAA receptors from rat cortex.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8910390     DOI: 10.1074/jbc.271.44.27902

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  GABAergic innervation organizes synaptic and extrasynaptic GABAA receptor clustering in cultured hippocampal neurons.

Authors:  Sean B Christie; Celia P Miralles; Angel L De Blas
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

2.  Neonatal development of the rat visual cortex: synaptic function of GABAA receptor alpha subunits.

Authors:  Laurens W J Bosman; Thomas W Rosahl; Arjen B Brussaard
Journal:  J Physiol       Date:  2002-11-15       Impact factor: 5.182

3.  Effect of the alpha subunit subtype on the macroscopic kinetic properties of recombinant GABA(A) receptors.

Authors:  Amber J Picton; Janet L Fisher
Journal:  Brain Res       Date:  2007-07-10       Impact factor: 3.252

4.  Age-dependent accumulation of soluble amyloid beta (Abeta) oligomers reverses the neuroprotective effect of soluble amyloid precursor protein-alpha (sAPP(alpha)) by modulating phosphatidylinositol 3-kinase (PI3K)/Akt-GSK-3beta pathway in Alzheimer mouse model.

Authors:  Sebastian Jimenez; Manuel Torres; Marisa Vizuete; Raquel Sanchez-Varo; Elisabeth Sanchez-Mejias; Laura Trujillo-Estrada; Irene Carmona-Cuenca; Cristina Caballero; Diego Ruano; Antonia Gutierrez; Javier Vitorica
Journal:  J Biol Chem       Date:  2011-04-01       Impact factor: 5.157

5.  Subunit composition and quantitative importance of hetero-oligomeric receptors: GABAA receptors containing alpha6 subunits.

Authors:  M Jechlinger; R Pelz; V Tretter; T Klausberger; W Sieghart
Journal:  J Neurosci       Date:  1998-04-01       Impact factor: 6.167

6.  The effects of repeated zolpidem treatment on tolerance, withdrawal-like symptoms, and GABAA receptor mRNAs profile expression in mice: comparison with diazepam.

Authors:  Brittany T Wright; Catherine F Gluszek; Scott A Heldt
Journal:  Psychopharmacology (Berl)       Date:  2014-02-15       Impact factor: 4.530

7.  Experience-dependent changes in excitatory and inhibitory receptor subunit expression in visual cortex.

Authors:  Brett R Beston; David G Jones; Kathryn M Murphy
Journal:  Front Synaptic Neurosci       Date:  2010-09-28

8.  In vivo modification of Abeta plaque toxicity as a novel neuroprotective lithium-mediated therapy for Alzheimer's disease pathology.

Authors:  Laura Trujillo-Estrada; Sebastian Jimenez; Vanessa De Castro; Manuel Torres; David Baglietto-Vargas; Ines Moreno-Gonzalez; Victoria Navarro; Raquel Sanchez-Varo; Elisabeth Sanchez-Mejias; Jose Carlos Davila; Marisa Vizuete; Antonia Gutierrez; Javier Vitorica
Journal:  Acta Neuropathol Commun       Date:  2013-11-12       Impact factor: 7.801

9.  Defective lysosomal proteolysis and axonal transport are early pathogenic events that worsen with age leading to increased APP metabolism and synaptic Abeta in transgenic APP/PS1 hippocampus.

Authors:  Manuel Torres; Sebastian Jimenez; Raquel Sanchez-Varo; Victoria Navarro; Laura Trujillo-Estrada; Elisabeth Sanchez-Mejias; Irene Carmona; Jose Carlos Davila; Marisa Vizuete; Antonia Gutierrez; Javier Vitorica
Journal:  Mol Neurodegener       Date:  2012-11-22       Impact factor: 14.195

10.  Reduction in focal ictal activity following transplantation of MGE interneurons requires expression of the GABAA receptor α4 subunit.

Authors:  Manoj K Jaiswal; Sotirios Keros; Mingrui Zhao; Melis Inan; Theodore H Schwartz; Stewart A Anderson; Gregg E Homanics; Peter A Goldstein
Journal:  Front Cell Neurosci       Date:  2015-04-09       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.